5318.KL DXN Holdings Bhd.
JNJ-5322 is designed to target three distinct proteins, aiming to improve treatment outcomes by addressing tumor heterogeneity and reducing resistance development. The trial involved 126 heavily ...
Find the latest Feytech Holdings Berhad (5322.KL) stock quote, history, news and other vital information to help you with your stock trading and investing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results